Header cover image

Taiwanese (TAIEX) Healthcare Services Industry Analysis

UpdatedNov 24, 2024
DataAggregated Company Financials
Companies22
  • 7D0.9%
  • 3M-5.3%
  • 1Y-9.1%
  • YTD-9.9%

The Healthcare Services industry has been flat over the last week, but Meribank Biotech has lost 5.0%. As for the longer term, the industry has declined 9.1% in the last year. Earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Taiwanese Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 24 Nov 2024NT$80.8bNT$39.9bNT$2.9b19.2x28.2x2x
Tue, 22 Oct 2024NT$84.1bNT$39.4bNT$2.8b23.8x30x2.1x
Thu, 19 Sep 2024NT$85.7bNT$39.4bNT$2.8b22.7x30.5x2.2x
Sat, 17 Aug 2024NT$84.5bNT$39.1bNT$2.8b23.2x30.6x2.2x
Mon, 15 Jul 2024NT$89.3bNT$38.9bNT$2.8b22.3x32.1x2.3x
Wed, 12 Jun 2024NT$87.3bNT$38.9bNT$2.8b22.9x31.4x2.2x
Fri, 10 May 2024NT$85.3bNT$38.7bNT$2.7b21.2x31x2.2x
Sun, 07 Apr 2024NT$88.9bNT$38.9bNT$2.8b22.4x31.4x2.3x
Tue, 05 Mar 2024NT$90.8bNT$37.9bNT$2.8b23.7x32.5x2.4x
Thu, 01 Feb 2024NT$87.0bNT$37.1bNT$2.8b22.8x31.5x2.3x
Sat, 30 Dec 2023NT$84.1bNT$37.1bNT$2.8b23.8x30.5x2.3x
Mon, 27 Nov 2023NT$84.3bNT$37.1bNT$2.8b24.1x30.6x2.3x
Wed, 25 Oct 2023NT$85.8bNT$37.0bNT$2.9b24x29.5x2.3x
Fri, 22 Sep 2023NT$88.9bNT$37.0bNT$2.9b25.1x30.6x2.4x
Sun, 20 Aug 2023NT$90.2bNT$37.1bNT$2.9b24.3x30.8x2.4x
Tue, 18 Jul 2023NT$95.8bNT$37.4bNT$3.0b23.7x32.3x2.6x
Thu, 15 Jun 2023NT$91.5bNT$37.0bNT$3.0b24.4x30.5x2.5x
Sat, 13 May 2023NT$92.5bNT$36.7bNT$3.0b22.1x30.4x2.5x
Mon, 10 Apr 2023NT$89.2bNT$37.0bNT$3.1b19.4x28.8x2.4x
Wed, 08 Mar 2023NT$84.6bNT$36.3bNT$3.3b19.3x25.6x2.3x
Fri, 03 Feb 2023NT$78.9bNT$36.5bNT$3.3b18.1x23.9x2.2x
Sun, 01 Jan 2023NT$71.8bNT$36.5bNT$3.3b16.3x21.8x2x
Tue, 29 Nov 2022NT$66.5bNT$36.5bNT$3.3b17.3x20.2x1.8x
Thu, 27 Oct 2022NT$61.6bNT$35.4bNT$3.1b16.5x19.7x1.7x
Sat, 24 Sep 2022NT$72.1bNT$35.4bNT$3.1b18.9x23x2x
Mon, 22 Aug 2022NT$73.8bNT$35.3bNT$3.1b18.7x23.7x2.1x
Wed, 20 Jul 2022NT$67.1bNT$33.6bNT$2.9b17.4x22.9x2x
Fri, 17 Jun 2022NT$66.1bNT$33.6bNT$2.9b19.6x22.6x2x
Sun, 15 May 2022NT$63.3bNT$32.9bNT$2.8b18.7x22.7x1.9x
Tue, 12 Apr 2022NT$67.2bNT$33.0bNT$2.9b20.3x23.5x2x
Thu, 10 Mar 2022NT$64.3bNT$32.4bNT$2.5b22.7x25.9x2x
Sat, 05 Feb 2022NT$58.9bNT$32.3bNT$2.5b20.8x23.7x1.8x
Mon, 03 Jan 2022NT$60.6bNT$32.3bNT$2.5b20.3x24.4x1.9x
Wed, 01 Dec 2021NT$59.4bNT$32.3bNT$2.5b19.1x23.9x1.8x
Price to Earnings Ratio

23.9x


Total Market Cap: NT$59.4bTotal Earnings: NT$2.5bTotal Revenue: NT$32.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Services Industry Price to Earnings3Y Average 27.4x202220232024
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 27.4x.
  • The industry is trading close to its 3-year average PS ratio of 2.2x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 4.8% per year over the last three years.
  • Revenues for these companies have grown 7.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market0.76%
Healthcare0.32%
Healthcare Services0.95%
Healthcare Services1.42%
Healthcare Distributors0.64%
Healthcare Facilities0%
Managed Healthcare0%
Industry PE
  • Investors are most optimistic about the Healthcare Facilities industry which is trading above its 3-year average PE ratio of 50.1x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 30.6x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Distributors industry, expecting annual earnings growth of 68% over the next 5 years.
  • This is better than its past earnings growth rate of 7.4% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
3218 Universal Vision BiotechnologyNT$215.501.9%
+NT$338.9m
-27.1%PE16.9x
1784 BIONETNT$92.806.8%
+NT$298.8m
70.8%PE84.3x
4104 Excelsior MedicalNT$87.001.0%
+NT$147.1m
5.2%PE18.5x
6879 TCI GENENT$51.004.9%
+NT$63.5m
-38.7%PE49.3x
4164 CHC Healthcare GroupNT$39.900.9%
+NT$58.4m
-34.6%PE20.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6637

NT$102.50

Medical Imaging

7D

1.0%

1Y

29.9%

4139

NT$29.95

Ma Kuang Healthcare Holding

7D

-3.1%

1Y

-19.1%

6615

NT$41.40

Sofiva GenomicsLtd

7D

2.7%

1Y

5.7%

6130

NT$26.00

Shangya Technology

7D

-3.3%

1Y

-28.0%

1784

NT$92.80

BIONET

7D

6.8%

1Y

70.8%

3218

NT$215.50

Universal Vision Biotechnology

7D

1.9%

1Y

-27.1%

4164

NT$39.90

CHC Healthcare Group

7D

0.9%

1Y

-34.6%

6879

NT$51.00

TCI GENE

7D

4.9%

1Y

-38.7%

4724

NT$30.35

Meribank Biotech

7D

-5.0%

1Y

-21.9%

6665

NT$20.75

Healthconn

7D

-3.9%

1Y

-28.1%

7713

NT$71.00

WeLeader Biomedical

7D

1.4%

1Y

n/a

6518

NT$25.85

Concord Medical

7D

-3.7%

1Y

9.5%